Stabin MG, Madsen MT, Zaidi H. Personalized dosimetry is a must for appropriate molecular radiotherapy. Med Phys. 2019;46:4713–6.

Article  PubMed  Google Scholar 

Ljungberg M, Sjögreen Gleisner K. Personalized dosimetry for radionuclide therapy using molecular imaging tools. Biomedicines. 2016;4:25.

Article  PubMed  PubMed Central  Google Scholar 

Chicheportiche A, et al. Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study. EJNMMI Phys. 2021;8:1–16.

Article  Google Scholar 

Chicheportiche A, Sason M, Godefroy J, Krausz Y, Zidan M, Oleinikov K, et al. Impact of single-time-point estimates of 177Lu-PRRT absorbed doses on patient management: validation of a trained multiple-linear-regression model in 159 patients and 477 therapy cycles. J Nucl Med. 2023;64:122.

Article  Google Scholar 

Peters SM, Mink MC, Privé BM, de Bakker M, de Lange F, Muselaers CH, et al. Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation. EJNMMI Res. 2023;13:6.

Article  PubMed  PubMed Central  Google Scholar 

Gustafsson J, Taprogge J. Theoretical aspects on the use of single-time-point dosimetry for radionuclide therapy. Phys Med Biol. 2022;67:025003.

Article  Google Scholar 

Madsen MT, Menda Y, O’Dorisio TM, O’Dorisio MS. Single time point dose estimate for exponential clearance. Med Phys. 2018;45:2318–24.

Article  PubMed  PubMed Central  Google Scholar 

Nautiyal A, Michopoulou S, Guy M. Dosimetry in Lu-177-DOTATATE peptide receptor radionuclide therapy: a systematic review. Clin Transl Imaging. 2024;12:157–75.

Article  Google Scholar 

Sandström M, Freedman N, Fröss-Baron K, Kahn T, Sundin A. Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points. EJNMMI Phys. 2020;7:1–15.

Article  Google Scholar 

Hänscheid H, Lapa C, Buck AK, Lassmann M, Werner RA. Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days. J Nucl Med. 2018;59:75–81.

Article  PubMed  Google Scholar 

Willowson KP, Eslick E, Ryu H, Poon A, Bernard EJ, Bailey DL. Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (‘Lutate’) therapy. EJNMMI Phys. 2018;5:1–9.

Article  Google Scholar 

Vergnaud L, Giraudet AL, Moreau A, Salvadori J, Imperiale A, Baudier T, et al. Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for 177Lu-DOTATATE therapy. EJNMMI Phys. 2022;9:37.

Article  PubMed  PubMed Central  Google Scholar 

Wang C, Peterson AB, Wong KK, Roseland ME, Schipper MJ, Dewaraja YK. Single-time-point imaging for dosimetry after [177Lu]Lu-DOTATATE: accuracy of existing methods and novel data-driven models for reducing sensitivity to Time-Point selection. J Nucl Med. 2023;64:1463–70.

Article  PubMed  PubMed Central  Google Scholar 

Jackson PA, Hofman MS, Hicks RJ, Scalzo M, Violet J. Radiation dosimetry in 177Lu-PSMA-617 therapy using a single posttreatment SPECT/CT scan: a novel methodology to generate time- and tissue-specific dose factors. J Nucl Med. 2020;61:1030–8.

Article  PubMed  PubMed Central  Google Scholar 

Brosch-Lenz J, Delker A, Völter F, Unterrainer LM, Kaiser L, Bartenstein P, et al. Toward single-time-point image-based dosimetry of 177Lu-PSMA-617 therapy. J Nucl Med. 2023;64:767–74.

Article  PubMed  PubMed Central  Google Scholar 

Hou X, Brosch J, Uribe C, Desy A, Böning G, Beauregard JM, et al. Feasibility of single-time-point dosimetry for radiopharmaceutical therapies. J Nucl Med. 2021;62:1006–11.

Article  PubMed  Google Scholar 

Hardiansyah D, Riana A, Beer AJ, Glatting G. Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model. Z Med Phys. 2023;33:70–81.

Article  PubMed  Google Scholar 

Hardiansyah D, Riana A, Beer AJ, Glatting G. Single-time-point dosimetry using model selection and nonlinear mixed-effects modelling: a proof of concept. EJNMMI Phys. 2023;10:1–12.

Article  Google Scholar 

Devasia TP, Dewaraja YK, Frey KA, Wong KK, Schipper MJ. A novel time-activity information-sharing approach using nonlinear mixed models for patient-specific dosimetry with reduced imaging time points: application in SPECT/CT after 177Lu-DOTATATE. J Nucl Med. 2021;62:1118–25.

Article  PubMed  PubMed Central  Google Scholar 

Zhao W, Esquinas PL, Frezza A, Hou X, Beauregard JM, Celler A. Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a 177Lu-DOTATATE patient study. Phys Med Biol. 2019;64:175006.

Article  PubMed  Google Scholar 

Gupta A, Lee MS, Kim JH, Lee DS, Lee JS. Preclinical voxel-based dosimetry in theranostics: a review. Nucl Med Mol Imaging (2010). 2020;54:86–97.

Marsh IR, Grudzinski J, Baiu DC, Besemer A, Hernandez R, Jeffery JJ, Weichert JP, Otto M, Bednarz BP. Preclinical pharmacokinetics and dosimetry studies of 124I/131I-CLR1404 for treatment of pediatric solid tumors in murine xenograft models. J Nucl Med. 2019;60:1414–20.

Article  PubMed  PubMed Central  Google Scholar 

Garrow AA, Andrews JPM, Gonzalez ZN, Corral CA, Portal C, Morgan TEF, Walton T, Wilson I, Newby DE, Lucatelli C. Preclinical dosimetry models and the prediction of clinical doses of novel positron emission tomography radiotracers. Sci Rep. 2020;10:15985.

Article  PubMed  PubMed Central  Google Scholar 

Stabin MG, Peterson TE, Holburn GE, Emmons MA. Voxel-based mouse and rat models for internal dose calculations. J Nucl Med. 2006;47:655–9.

PubMed  Google Scholar 

Biglin ER, Price GJ, Chadwick AL, Aitkenhead AH, Williams KJ, Kirkby KJ. Preclinical dosimetry: exploring the use of small animal phantoms. Radiat Oncol. 2019;14:1–10.

Article  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:372.

Article  Google Scholar 

Garske U, Sandström M, Johansson S, Sundin A, Granberg D, Eriksson B, et al. Minor changes in effective half-life during fractionated 177Lu-octreotate therapy. Acta Oncol (Madr). 2012;51:86–96.

Article  Google Scholar 

Sundlöv A, Gustafsson J, Brolin G, Mortensen N, Hermann R, Bernhardt P, et al. Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy. EJNMMI Phys. 2018;5:1–19.

Article  Google Scholar 

Xue S, Gafita A, Dong C, Zhao Y, Tetteh G, Menze BH, et al. Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy. Eur J Nucl Med Mol Imaging. 2022;49:4064–72.

Article  PubMed  PubMed Central  Google Scholar 

Peterson AB, Mirando DM, Dewaraja YK. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in patients and clinically realistic simulations. EJNMMI Res. 2023;13:57.

Article  PubMed  PubMed Central  Google Scholar 

Alipour R, Jackson P, Bressel M, Hogg A, Callahan J, Hicks RJ, et al. The relationship between tumour dosimetry, response, and overall survival in patients with unresectable neuroendocrine neoplasms (NEN) treated with 177Lu DOTATATE (LuTate). Eur J Nucl Med Mol Imaging. 2023;50:2997–10.

Article  PubMed  PubMed Central  Google Scholar 

Del Prete M, Arsenault F, Saighi N, Zhao W, Buteau FA, Celler A, et al. Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT. EJNMMI Phys. 2018;5:1–20.

Google Scholar 

Kao YH. A simplified general schema for rapid single time-point marrow predictive dosimetry. Nucl Med Commun. 2023;44:1187–8.

Article  PubMed  Google Scholar 

Chen G, Lu Z, Jiang H, Afshar-Oromieh A, Rominger A, Shi K, Mok GSP. Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT images at two imaging time points. Front Med. 2023;10:1246881.

Article  Google Scholar 

Mok GSP, Dewaraja YK. Recent advances in voxel-based targeted radionuclide therapy dosimetry. Quant Imaging Med Surg. 2021;11:483–9.

Article  PubMed  PubMed Central  Google Scholar 

Gear J, Stokke C, Terwinghe C, Gnesin S, Sandström M, Tran-Gia J, et al. EANM enabling guide: how to improve the accessibility of clinical dosimetry. Eur J Nucl Med Mol Imaging. 2023;50:1861–8.

Article  PubMed  PubMed Central